Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UCHL1 | P09936 | 1/20 | 0.43 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 1/20 | 0.43 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PPOX | P50336 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 9/20 | 0.36 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | GAPDH | P04406 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29414113 | 1.00 | UCHL1 (0.43) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| SCHEMBL29202777 | 0.97 | UCHL1 (0.41) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| Ethylene SCHEMBL16860555 | 0.94 | UCHL1 (0.39) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| Ethane SCHEMBL29094893 | 0.94 | UCHL1 (0.39) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| SCHEMBL13578741 | 0.84 | PPOX (0.37) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| SCHEMBL3143690 | 0.81 | UCHL1 (0.35) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| SCHEMBL9040639 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TSHRPPOXCES1DNMT1 | |
| SCHEMBL3685169 | 0.79 | PPOX (0.31) | PPOX | |
| SCHEMBL11411965 | 0.79 | UCHL1 (0.33) | UCHL1UCHL3ECE1MUS81ALDH1A1 | |
| SCHEMBL9154113 | 0.77 | UCHL1 (0.32) | UCHL1UCHL3ECE1MUS81ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 863 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12365678-B2 | Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl) cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b] pyridine and intermediates | ASTRAZENECA AB (SE) | 2025-07-22 | — | — | US | claimed |
| CN-119534412-A | Method for rapidly detecting out-of-standard methanol in gasoline on site | 福建师范大学 | 2025-02-28 | — | — | CN | claimed |
| US-20250002522-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2025-01-02 | — | — | US | claimed |
| CN-118414345-A | Oligosaccharide compounds and complexes | 生物技术公司 | 2024-07-30 | — | — | CN | claimed |
| EP-4402150-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | BioNTech SE (DE) | 2024-07-24 | — | — | EP | claimed |
| CN-113195728-B | Pharmaceutical process and intermediates | 阿斯利康(瑞典)有限公司 | 2024-07-16 | — | — | CN | claimed |
| EP-4286394-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | BioNTech SE (DE) | 2023-12-06 | — | — | EP | claimed |
| CN-115417849-B | Method for catalytic synthesis of 3-isochromone | 河南省化工研究所有限责任公司 | 2023-09-26 | — | — | CN | claimed |
| CN-116640066-A | Method for synthesizing alkyl unnatural amino acid derivative by photocatalysis | 大连理工大学 | 2023-08-25 | — | — | CN | claimed |
| CN-116601163-A | Protected disaccharides, methods for their preparation, their use in the synthesis of zwitterionic oligosaccharides and conjugates thereof | 巴斯德研究所 | 2023-08-15 | — | — | CN | claimed |
| US-4400509-A | WITH HEXAMETHYLDISILANE WITH AN ORGANONITROGEN CATALYST | GIST-BROCADES N.V. (NL) | 1983-08-23 | — | — | US | claimed |
| EP-0043630-A2 | Improved process for the silylation of organic compounds with 1,1,1-trimethyl-N-(trimethylsilyl)silanamine by means of catalysis with certain nitrogen containing compounds | GIST-BROCADES N.V. (NL) | 1982-01-13 | — | — | EP | claimed |
| EP-0003258-B1 | PREPARATION OF N-CHLOROIMIDES AND A NOVEL N-CHLOROIMIDE | ELI LILLY AND COMPANY (US) | 1982-01-13 | — | — | EP | claimed |
| US-4273674-A | HALOGENATED PHTHALIMIDES | GENERAL ELECTRIC COMPANY (US) | 1981-06-16 | — | — | US | claimed |
| US-4256507-A | FLAVANTHRONE, PYRANTHRONE, INDANTHRONE, INDIGO, QUINACRIDONE, PERYLENE DIANHYDRIDE OR DIIMIDE PIGMENTS SUBSTITUTED WITH PHTHALIMIDO-METHYL GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | claimed |
| EP-0014458-A1 | Pigment preparations for lacquers and printing dyes | BASF Aktiengesellschaft (DE) | 1980-08-20 | — | — | EP | claimed |
| US-4208489-A | AN ALKALI METAL SALT AND A TETRAHALOGENOPHTHALIMIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1980-06-17 | — | — | US | claimed |
| US-4204428-A | Thermal detection system for failure in electrical apparatus and thermal detecting paint compositions | GENERAL ELECTRIC COMPANY (US) | 1980-05-27 | — | — | US | claimed |
| EP-0003258-A1 | Preparation of N-chloroimides and a novel N-chloroimide | ELI LILLY AND COMPANY (US) | 1979-08-08 | — | — | EP | claimed |
| US-4035383-A | Eutectic process for preparing polychloro copper phthalocyanine | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-07-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12365678-B2 | Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl) cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b] pyridine and intermediates | TPMT, CYP3A7, HTR7 | UCHL1 2911/4885UCHL3 2853/4885ECE1 4070/4885 |
| US-20250002522-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | OSTC, FUT6, MAN2B2 | UCHL1 4128/4885UCHL3 4146/4885ECE1 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.